AUGUST - 20225TECH OUTLOOKAnalytical Considerations for Combination ProductsIN MY OPINIONJennifer L. Riter, Sr. Director, Analytical Services, West Pharmaceutical Services, Inc.08CXO INSIGHTSLAST WORDAnalytics as a Competitive Advantage takes 3 Things­Access, Cleanliness, and ActionRevamping Workflow in Pharma Industry with Technology Bozidar Jovicevic, VP, Global Head of Digital Medicines, Sanofi20Data Science in R&D: It Is about Culture!Philippe MARC, Executive Director, Global Head of Integrated Data Science, Novartis23What the New EMA Draft "Guideline on Computerized Systems and Electronic Data" Means to Your SystemsCathlin Shapiro, Director, Technology Quality Assurance, Parexel24Impact of Real-World Evidence and Digital Innovation in HealthcareKelly H. Zou, Head, Global Medical Analytics and Real-World Evidence, Viatris26The Secret to Resolving Microbial Contamination InvestigationsJessica Rayser, Associate Director of Product Management, Charles River Laboratories28C O N TE N TSMatt Southwick, Executive Director Clinical Systems and Analytical Reporting, Amgen30
< Page 4 | Page 6 >